In 2019 the Pickett lab showed that ALT cells are hypersensitive to replication stress caused by FANCM depletion [50], compared to telomerase-positive cancer cells, highlighting FANCM as an ALT therapeutic target. The gene discussed is FANCM; the disease is cancer.